Hosted on MSN59m
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback